[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2014 [#4]

Announcement Date
23-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
QoQ- 23.16%
YoY- 70.01%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 2,012,216 1,969,498 1,887,616 2,122,933 1,994,440 1,987,488 1,874,688 4.82%
PBT 118,673 127,336 154,448 125,580 116,968 125,562 152,636 -15.43%
Tax -27,282 -30,200 -26,744 -31,355 -40,162 -40,356 -46,052 -29.44%
NP 91,390 97,136 127,704 94,225 76,805 85,206 106,584 -9.73%
-
NP to SH 90,642 96,022 127,176 93,844 76,196 84,384 104,868 -9.25%
-
Tax Rate 22.99% 23.72% 17.32% 24.97% 34.34% 32.14% 30.17% -
Total Cost 1,920,825 1,872,362 1,759,912 2,028,708 1,917,634 1,902,282 1,768,104 5.67%
-
Net Worth 534,070 527,991 528,173 525,526 507,513 502,162 515,022 2.44%
Dividend
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Div 79,389 72,469 72,494 72,486 55,239 41,415 41,408 54.26%
Div Payout % 87.59% 75.47% 57.00% 77.24% 72.50% 49.08% 39.49% -
Equity
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Net Worth 534,070 527,991 528,173 525,526 507,513 502,162 515,022 2.44%
NOSH 258,880 258,819 258,908 258,880 258,935 258,846 258,805 0.01%
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 4.54% 4.93% 6.77% 4.44% 3.85% 4.29% 5.69% -
ROE 16.97% 18.19% 24.08% 17.86% 15.01% 16.80% 20.36% -
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 777.28 760.95 729.07 820.05 770.25 767.82 724.36 4.80%
EPS 35.01 37.10 49.12 36.25 29.43 32.60 40.52 -9.27%
DPS 30.67 28.00 28.00 28.00 21.33 16.00 16.00 54.24%
NAPS 2.063 2.04 2.04 2.03 1.96 1.94 1.99 2.42%
Adjusted Per Share Value based on latest NOSH - 258,794
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 139.62 136.65 130.97 147.30 138.38 137.90 130.07 4.83%
EPS 6.29 6.66 8.82 6.51 5.29 5.85 7.28 -9.27%
DPS 5.51 5.03 5.03 5.03 3.83 2.87 2.87 54.40%
NAPS 0.3706 0.3663 0.3665 0.3646 0.3521 0.3484 0.3573 2.46%
Price Multiplier on Financial Quarter End Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 -
Price 6.50 7.13 6.00 4.58 4.63 4.61 4.46 -
P/RPS 0.84 0.94 0.82 0.56 0.60 0.60 0.62 22.41%
P/EPS 18.56 19.22 12.21 12.63 15.73 14.14 11.01 41.59%
EY 5.39 5.20 8.19 7.91 6.36 7.07 9.09 -29.39%
DY 4.72 3.93 4.67 6.11 4.61 3.47 3.59 19.99%
P/NAPS 3.15 3.50 2.94 2.26 2.36 2.38 2.24 25.49%
Price Multiplier on Announcement Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 26/11/15 17/08/15 18/05/15 23/02/15 21/11/14 21/08/14 14/05/14 -
Price 6.50 5.65 6.91 5.28 4.45 4.62 4.70 -
P/RPS 0.84 0.74 0.95 0.64 0.58 0.60 0.65 18.62%
P/EPS 18.56 15.23 14.07 14.57 15.12 14.17 11.60 36.75%
EY 5.39 6.57 7.11 6.87 6.61 7.06 8.62 -26.85%
DY 4.72 4.96 4.05 5.30 4.79 3.46 3.40 24.41%
P/NAPS 3.15 2.77 3.39 2.60 2.27 2.38 2.36 21.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment